Skip to content
  • Wednesday, 14 October 2026
  • 10:02 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Pharmaceutical R&D

Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership

Teuku Ryan Oct 14, 2026 0

Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…

Read More
Science News: A Century of Independent Journalism and the Evolution of Scientific LiteracyEvolutionary "Cheat Sheet" for Warning Colors Used for Over 120 Million Years Suggests Life’s Path is More PredictableUC San Diego Researchers Unveil Hybrid Piezoelectric Chip Design to Enhance Data Center Power Efficiency and GPU PerformanceAmazon Bio Discovery Accelerates Drug Development, Cuts MSK Antibody Design from a Year to Weeks
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning PractitionersScience News: A Century of Commitment to Scientific Literacy and Public EngagementPfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
Lana Keisha Oct 14, 2026
Data Science & Bioinformatics
Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning Practitioners
Evan Lee Salim Oct 14, 2026
Environmental & Analytical Chemistry
Science News: A Century of Commitment to Scientific Literacy and Public Engagement
Abdurrohim Arsyad Oct 14, 2026
Pharmaceutical R&D
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Teuku Ryan Oct 14, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ